martes, 30 de diciembre de 2025
With the Wegovy pill, Novo Nordisk undercuts Eli Lilly in direct-to-consumer market Patients using insurance may not see savings with Novo’s pricing strategy
https://www.statnews.com/2025/12/29/wegovy-pill-price-novo-nordisk-strategy-weight-loss-drugs/
By Elaine ChenDec. 29, 2025
Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario